chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Dizziness, Nausea, Pain
Clinical narrative: Weakness; Dizziness; Ache; Fever; Chills; Nausea; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Mar-2021 and was forwarded to Moderna on 05-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), DIZZINESS (Dizziness), PAIN (Ache), PYREXIA (Fever) and CHILLS (Chills) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in June 2020.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced ASTHENIA (Weakness), DIZZINESS (Dizziness), PAIN (Ache), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea). At the time of the report, ASTHENIA (Weakness), DIZZINESS (Dizziness), PAIN (Ache), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: TCR attached. NNI.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Weakness; Dizziness; Ache; Fever; Chills; Nausea; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Mar-2021 and was forwarded to Moderna on 05-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), DIZZINESS (Dizziness), PAIN (Ache), PYREXIA (Fever) and CHILLS (Chills) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in June 2020.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced ASTHENIA (Weakness), DIZZINESS (Dizziness), PAIN (Ache), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea). At the time of the report, ASTHENIA (Weakness), DIZZINESS (Dizziness), PAIN (Ache), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: TCR attached. NNI.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: Nausea; Dizziness; light headedness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), DIZZINESS (light headedness) and NAUSEA (Nausea) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 05-Feb-2021, the patient experienced DIZZINESS (Dizziness) and DIZZINESS (light headedness). On an unknown date, the patient experienced NAUSEA (Nausea). At the time of the report, DIZZINESS (Dizziness), DIZZINESS (light headedness) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.    No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 24-Mar-2021: No specific follow-up information recorded.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Blood urine present, Chills, Pain
Clinical narrative: blood in the urine; Aches; chills; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD URINE PRESENT (blood in the urine), PAIN (Aches) and CHILLS (chills) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced CHILLS (chills). On 09-Feb-2021, the patient experienced BLOOD URINE PRESENT (blood in the urine) and PAIN (Aches). At the time of the report, BLOOD URINE PRESENT (blood in the urine), PAIN (Aches) and CHILLS (chills) outcome was unknown.            Concomitant product use was not provided by the reporter.  Treatment medication included paracetamol.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, SARS-CoV-2 test, SARS-CoV-2 test positive, Vaccination site pain
Clinical narrative: Felt terrible; exhausted; arm so sore, felt like she got run over by a truck; diagnosed with Covid19; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (diagnosed with Covid19), FEELING ABNORMAL (Felt terrible), FATIGUE (exhausted) and VACCINATION SITE PAIN (arm so sore, felt like she got run over by a truck) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (diagnosed with Covid19). On an unknown date, the patient experienced FEELING ABNORMAL (Felt terrible), FATIGUE (exhausted) and VACCINATION SITE PAIN (arm so sore, felt like she got run over by a truck). At the time of the report, SARS-COV-2 TEST POSITIVE (diagnosed with Covid19), FEELING ABNORMAL (Felt terrible), FATIGUE (exhausted) and VACCINATION SITE PAIN (arm so sore, felt like she got run over by a truck) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Adverse drug reaction, Adverse event, Adverse reaction
Clinical narrative: Pretty significant side effects for 4 or 5 days; Reaction to the first dose of the Moderna vaccine; Most severe side effects; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Feb-2021 and was forwarded to Moderna on 11-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE DRUG REACTION (Pretty significant side effects for 4 or 5 days), ADVERSE REACTION (Reaction to the first dose of the Moderna vaccine) and ADVERSE EVENT (Most severe side effects) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE DRUG REACTION (Pretty significant side effects for 4 or 5 days), ADVERSE REACTION (Reaction to the first dose of the Moderna vaccine) and ADVERSE EVENT (Most severe side effects). At the time of the report, ADVERSE DRUG REACTION (Pretty significant side effects for 4 or 5 days), ADVERSE REACTION (Reaction to the first dose of the Moderna vaccine) and ADVERSE EVENT (Most severe side effects) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported. No treatment medication were reported.
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: Metallic taste; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Metallic taste) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for COVID-19: Pfizer vaccine. Concurrent medical conditions included Tardive dyskinesia.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSGEUSIA (Metallic taste). At the time of the report, DYSGEUSIA (Metallic taste) outcome was unknown. Not Provided          Concomitant medication list was not provided. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Ear discomfort, Ear pain, Headache, Rhinorrhoea, Vaccination site pain
Clinical narrative: ear pain; Ear disturbance; vertigo; runny nose; headache; Pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (ear pain), EAR DISCOMFORT (Ear disturbance), VERTIGO (vertigo), RHINORRHOEA (runny nose) and VACCINATION SITE PAIN (Pain at the injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetic, Blood pressure management and Seasonal allergy. Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) and AMLODIPINE BESILATE (NORVASC) for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE PAIN (Pain at the injection site). On 07-Feb-2021, the patient experienced EAR PAIN (ear pain), EAR DISCOMFORT (Ear disturbance), VERTIGO (vertigo), RHINORRHOEA (runny nose) and HEADACHE (headache). The patient was treated with AZITHROMYCIN (Z-PAK) for Adverse event, at an unspecified dose and frequency. At the time of the report, EAR PAIN (ear pain), EAR DISCOMFORT (Ear disturbance), VERTIGO (vertigo), RHINORRHOEA (runny nose), VACCINATION SITE PAIN (Pain at the injection site) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other treatment medication included nasal spray.
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: ear pain; Ear disturbance; vertigo; runny nose; headache; Pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (ear pain), EAR DISCOMFORT (Ear disturbance), VERTIGO (vertigo), RHINORRHOEA (runny nose) and VACCINATION SITE PAIN (Pain at the injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetic, Blood pressure management and Seasonal allergy. Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) and AMLODIPINE BESILATE (NORVASC) for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE PAIN (Pain at the injection site). On 07-Feb-2021, the patient experienced EAR PAIN (ear pain), EAR DISCOMFORT (Ear disturbance), VERTIGO (vertigo), RHINORRHOEA (runny nose) and HEADACHE (headache). The patient was treated with AZITHROMYCIN (Z-PAK) for Adverse event, at an unspecified dose and frequency. At the time of the report, EAR PAIN (ear pain), EAR DISCOMFORT (Ear disturbance), VERTIGO (vertigo), RHINORRHOEA (runny nose), VACCINATION SITE PAIN (Pain at the injection site) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other treatment medication included nasal spray.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site warmth, Pain, Peripheral swelling
Clinical narrative: arm swollen; hot and red.; still is very warm; little pain, but no itching.; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm swollen), ERYTHEMA (hot and red.), INJECTION SITE WARMTH (still is very warm) and PAIN (little pain, but no itching.) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Breast cancer. Concomitant products included BUPROPION HYDROCHLORIDE (WELLBUTRIN) for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced PERIPHERAL SWELLING (arm swollen), ERYTHEMA (hot and red.), INJECTION SITE WARMTH (still is very warm) and PAIN (little pain, but no itching.). At the time of the report, PERIPHERAL SWELLING (arm swollen), ERYTHEMA (hot and red.) and PAIN (little pain, but no itching.) had not resolved and INJECTION SITE WARMTH (still is very warm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient is getting Radiation and hormonal treatment for breast cancer. Also patient takes blood pressure medications.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: red patch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (red patch) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included No adverse event (no adverse event).    On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE RASH (red patch). At the time of the report, VACCINATION SITE RASH (red patch) outcome was unknown.            no concomitant medication and treatment provided
Sex: U
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and PYREXIA (Fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported by the reporter.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 25-Apr-2021: Follow-up information received on 25-Apr-2021 contains non-significant information.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass
Clinical narrative: lump at injection site; Lump is red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (lump at injection site) and VACCINATION SITE ERYTHEMA (Lump is red) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE MASS (lump at injection site) and VACCINATION SITE ERYTHEMA (Lump is red). On 06-Feb-2021, VACCINATION SITE MASS (lump at injection site) and VACCINATION SITE ERYTHEMA (Lump is red) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medication and treatment provided
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Influenza like illness, Pyrexia, Tremor, Vaccination site pruritus
Clinical narrative: fever 102F; chills; shakes; vomiting,; flu like symptoms; swelling at injection site; itchiness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever 102F), CHILLS (chills), TREMOR (shakes), VOMITING (vomiting,) and INFLUENZA LIKE ILLNESS (flu like symptoms) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included ATORVASTATIN, OMEPRAZOLE, ATENOLOL, ALLOPURINOL, AMLODIPINE, ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), ACETYLSALICYLIC ACID (BABY ASPIRIN), CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE (VITAMIN B 1-6-12), MULTIVITAMIN FOR WOMEN, CALCIUM and GLUCOSAMINE for an unknown indication.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced PYREXIA (fever 102F), CHILLS (chills), TREMOR (shakes), VOMITING (vomiting,), INFLUENZA LIKE ILLNESS (flu like symptoms), VACCINATION SITE SWELLING (swelling at injection site) and VACCINATION SITE PRURITUS (itchiness at injection site). The patient was treated with PARACETAMOL (TYLENOL) for Chills, Fever and Swelling of injection site, at an unspecified dose and frequency. On 10-Feb-2021, PYREXIA (fever 102F), CHILLS (chills), TREMOR (shakes) and INFLUENZA LIKE ILLNESS (flu like symptoms) had resolved, VOMITING (vomiting,) outcome was unknown. At the time of the report, VACCINATION SITE SWELLING (swelling at injection site) and VACCINATION SITE PRURITUS (itchiness at injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vomiting
Clinical narrative: fever 102F; chills; shakes; vomiting,; flu like symptoms; swelling at injection site; itchiness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever 102F), CHILLS (chills), TREMOR (shakes), VOMITING (vomiting,) and INFLUENZA LIKE ILLNESS (flu like symptoms) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included ATORVASTATIN, OMEPRAZOLE, ATENOLOL, ALLOPURINOL, AMLODIPINE, ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), ACETYLSALICYLIC ACID (BABY ASPIRIN), CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE (VITAMIN B 1-6-12), MULTIVITAMIN FOR WOMEN, CALCIUM and GLUCOSAMINE for an unknown indication.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced PYREXIA (fever 102F), CHILLS (chills), TREMOR (shakes), VOMITING (vomiting,), INFLUENZA LIKE ILLNESS (flu like symptoms), VACCINATION SITE SWELLING (swelling at injection site) and VACCINATION SITE PRURITUS (itchiness at injection site). The patient was treated with PARACETAMOL (TYLENOL) for Chills, Fever and Swelling of injection site, at an unspecified dose and frequency. On 10-Feb-2021, PYREXIA (fever 102F), CHILLS (chills), TREMOR (shakes) and INFLUENZA LIKE ILLNESS (flu like symptoms) had resolved, VOMITING (vomiting,) outcome was unknown. At the time of the report, VACCINATION SITE SWELLING (swelling at injection site) and VACCINATION SITE PRURITUS (itchiness at injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: sore shoulder; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (sore shoulder) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Lupus syndrome. Concomitant products included HYDROXYCHLOROQUINE for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced ARTHRALGIA (sore shoulder). On 03-Feb-2021, ARTHRALGIA (sore shoulder) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no treatment provided
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Heart rate increased
Clinical narrative: rapid heartbeat that lasted for half an hour; headache; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (rapid heartbeat that lasted for half an hour) and HEADACHE (headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no adverse events).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced HEART RATE INCREASED (rapid heartbeat that lasted for half an hour) and HEADACHE (headache). On 10-Feb-2021, HEART RATE INCREASED (rapid heartbeat that lasted for half an hour) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medication provided no treatment taken   This case was linked to MOD21-029391 (E2B Linked Report).; Sender's Comments:  MOD21-029391:Duplicate report
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea, Vaccination site pain, Vomiting
Clinical narrative: nausea; vomiting; diarrhea; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), VOMITING (vomiting), DIARRHOEA (diarrhea) and VACCINATION SITE PAIN (sore arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     The patient's past medical history included Unspecified immunity deficiency (due to blood panel problem) since an unknown date.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced NAUSEA (nausea), VOMITING (vomiting), DIARRHOEA (diarrhea) and VACCINATION SITE PAIN (sore arm). The patient was treated with BISMUTH SUBSALICYLATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE]) for Diarrhea, Nausea and Vomiting, at an unspecified dose and frequency. At the time of the report, NAUSEA (nausea), VOMITING (vomiting), DIARRHOEA (diarrhea) and VACCINATION SITE PAIN (sore arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medication provided. patient currently takes lots of medicine to low immunity.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 antibody test positive
Clinical narrative: Tested positive for IgG/IgM; Possible Covid-19; This spontaneous case was reported by a physician and describes the occurrence of SARS-COV-2 ANTIBODY TEST POSITIVE (Tested positive for IgG/IgM) and COVID-19 (Possible Covid-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 ANTIBODY TEST POSITIVE (Tested positive for IgG/IgM) and COVID-19 (Possible Covid-19). At the time of the report, SARS-COV-2 ANTIBODY TEST POSITIVE (Tested positive for IgG/IgM) and COVID-19 (Possible Covid-19) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication list was not provided. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: had Covid-19 after 1st dose of the vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of COVID-19 (had Covid-19 after 1st dose of the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history).    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (had Covid-19 after 1st dose of the vaccine). At the time of the report, COVID-19 (had Covid-19 after 1st dose of the vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant medication provided patient has taken monoclonal antibody infusion treatment
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Formication, Hyperhidrosis, Lymphadenopathy, Nausea
Clinical narrative: throat hurts glands are swollen; strange, odd feeling; crawling sensation in her left arm,upper body part,chest; heart was pounding fast; sweating; nauseated; This spontaneous case was reported by a consumer and describes the occurrence of FORMICATION (crawling sensation in her left arm,upper body part,chest), PALPITATIONS (heart was pounding fast), HYPERHIDROSIS (sweating), NAUSEA (nauseated) and LYMPHADENOPATHY (throat hurts glands are swollen) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Otitis externa and Drug allergy. Concomitant products included ERYTHROMYCIN for Sore throat and Glands swollen.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced FORMICATION (crawling sensation in her left arm,upper body part,chest), PALPITATIONS (heart was pounding fast), HYPERHIDROSIS (sweating), NAUSEA (nauseated) and FEELING ABNORMAL (strange, odd feeling). On 12-Feb-2021, the patient experienced LYMPHADENOPATHY (throat hurts glands are swollen). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, FORMICATION (crawling sensation in her left arm,upper body part,chest), PALPITATIONS (heart was pounding fast), HYPERHIDROSIS (sweating), NAUSEA (nauseated), LYMPHADENOPATHY (throat hurts glands are swollen) and FEELING ABNORMAL (strange, odd feeling) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: throat hurts glands are swollen; strange, odd feeling; crawling sensation in her left arm,upper body part,chest; heart was pounding fast; sweating; nauseated; This spontaneous case was reported by a consumer and describes the occurrence of FORMICATION (crawling sensation in her left arm,upper body part,chest), PALPITATIONS (heart was pounding fast), HYPERHIDROSIS (sweating), NAUSEA (nauseated) and LYMPHADENOPATHY (throat hurts glands are swollen) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Otitis externa and Drug allergy. Concomitant products included ERYTHROMYCIN for Sore throat and Glands swollen.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced FORMICATION (crawling sensation in her left arm,upper body part,chest), PALPITATIONS (heart was pounding fast), HYPERHIDROSIS (sweating), NAUSEA (nauseated) and FEELING ABNORMAL (strange, odd feeling). On 12-Feb-2021, the patient experienced LYMPHADENOPATHY (throat hurts glands are swollen). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, FORMICATION (crawling sensation in her left arm,upper body part,chest), PALPITATIONS (heart was pounding fast), HYPERHIDROSIS (sweating), NAUSEA (nauseated), LYMPHADENOPATHY (throat hurts glands are swollen) and FEELING ABNORMAL (strange, odd feeling) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Fatigue, Headache
Clinical narrative: has not received her second shot; Developed sharp pains in front of her legs and in her quadriceps; Diarrhea; Joint pain; Fatigue; Headache; Chills; Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness), DIARRHOEA (Diarrhea), PAIN IN EXTREMITY (Developed sharp pains in front of her legs and in her quadriceps), PRODUCT DOSE OMISSION ISSUE (has not received her second shot) and ARTHRALGIA (Joint pain) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness). On 16-Jan-2021, the patient experienced DIARRHOEA (Diarrhea), ARTHRALGIA (Joint pain), FATIGUE (Fatigue), HEADACHE (Headache) and CHILLS (Chills). On 20-Jan-2021, the patient experienced PAIN IN EXTREMITY (Developed sharp pains in front of her legs and in her quadriceps). In February 2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (has not received her second shot). On 20-Jan-2021, PAIN IN EXTREMITY (Arm soreness), ARTHRALGIA (Joint pain), FATIGUE (Fatigue), HEADACHE (Headache) and CHILLS (Chills) had resolved. In February 2021, PRODUCT DOSE OMISSION ISSUE (has not received her second shot) had resolved. At the time of the report, DIARRHOEA (Diarrhea) and PAIN IN EXTREMITY (Developed sharp pains in front of her legs and in her quadriceps) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing was delayed on an unknown date.       No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Patient was suspicious about the call so representative provided her Moderna Medical Information number to leave her details. On 22-Apr-2021: patient reported she delayed her second dose of the vaccine on advice from her HCP, because of the side effects she experienced with first dose. Her HCP advised her to wait for 4 to 6 months, she plans on getting the second dose. Action take with vaccine was updated.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Product dose omission issue
Clinical narrative: has not received her second shot; Developed sharp pains in front of her legs and in her quadriceps; Diarrhea; Joint pain; Fatigue; Headache; Chills; Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness), DIARRHOEA (Diarrhea), PAIN IN EXTREMITY (Developed sharp pains in front of her legs and in her quadriceps), PRODUCT DOSE OMISSION ISSUE (has not received her second shot) and ARTHRALGIA (Joint pain) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness). On 16-Jan-2021, the patient experienced DIARRHOEA (Diarrhea), ARTHRALGIA (Joint pain), FATIGUE (Fatigue), HEADACHE (Headache) and CHILLS (Chills). On 20-Jan-2021, the patient experienced PAIN IN EXTREMITY (Developed sharp pains in front of her legs and in her quadriceps). In February 2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (has not received her second shot). On 20-Jan-2021, PAIN IN EXTREMITY (Arm soreness), ARTHRALGIA (Joint pain), FATIGUE (Fatigue), HEADACHE (Headache) and CHILLS (Chills) had resolved. In February 2021, PRODUCT DOSE OMISSION ISSUE (has not received her second shot) had resolved. At the time of the report, DIARRHOEA (Diarrhea) and PAIN IN EXTREMITY (Developed sharp pains in front of her legs and in her quadriceps) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing was delayed on an unknown date.       No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Patient was suspicious about the call so representative provided her Moderna Medical Information number to leave her details. On 22-Apr-2021: patient reported she delayed her second dose of the vaccine on advice from her HCP, because of the side effects she experienced with first dose. Her HCP advised her to wait for 4 to 6 months, she plans on getting the second dose. Action take with vaccine was updated.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Headache, Myalgia, Nausea
Clinical narrative: Almost passed out; Pounding heart; extreme soreness; Weakness; Nauseous; Aches/pain; Chills; Severe headache; A spontaneous report was received from a consumer concerning a 66-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and who experienced the events  almost passed out, aches/ pain, extreme soreness, pounding heart, weakness, chills, severe headache and nausea.  The patient's medical history was not provided. Concomitant medications reported were levothyroxine, fish oil and multivitamins.  On 11-Feb-2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot: unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 11-Feb-2021, the patient experienced chills, severe headache, aches, pain, and took ibuprofen. Those side effects went away. On 12-Feb-2021 she experienced extreme soreness, pounding heart, weakness, nauseous, and almost passed out.  She called the paramedic to evaluate her symptoms.  No further details were provided.  Treatment for the events included ibuprofen.  Action taken with mRNA-1273 in response to the events was unknown.   The outcomes of the events, chills, severe headache, aches/pain, extreme soreness, pounding heart, weakness, nausea and almost passed out, were considered unknown.  The reporter assessed the events almost passed out, aches/ pain, extreme soreness, pouring heart, weakness, chills, severe headache, nauseous as possibly related to study drug; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Palpitations, Presyncope
Clinical narrative: Almost passed out; Pounding heart; extreme soreness; Weakness; Nauseous; Aches/pain; Chills; Severe headache; A spontaneous report was received from a consumer concerning a 66-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and who experienced the events  almost passed out, aches/ pain, extreme soreness, pounding heart, weakness, chills, severe headache and nausea.  The patient's medical history was not provided. Concomitant medications reported were levothyroxine, fish oil and multivitamins.  On 11-Feb-2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot: unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 11-Feb-2021, the patient experienced chills, severe headache, aches, pain, and took ibuprofen. Those side effects went away. On 12-Feb-2021 she experienced extreme soreness, pounding heart, weakness, nauseous, and almost passed out.  She called the paramedic to evaluate her symptoms.  No further details were provided.  Treatment for the events included ibuprofen.  Action taken with mRNA-1273 in response to the events was unknown.   The outcomes of the events, chills, severe headache, aches/pain, extreme soreness, pounding heart, weakness, nausea and almost passed out, were considered unknown.  The reporter assessed the events almost passed out, aches/ pain, extreme soreness, pouring heart, weakness, chills, severe headache, nauseous as possibly related to study drug; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Abdominal pain upper, Fatigue, Feeling abnormal, Headache
Clinical narrative: Black out like feeling; Sweating; Bad adnominal pain; Felt double over pain in stomach; Thirstiness; Fatigue; Headache; Nausea; Blurry Vision; Moody; Swelling in left armpit; This spontaneous report was received from a consumer concerning a female patient (age not provided) who experienced black out like feeling (feeling abnormal), blurry vision (vision blurred), moody (mood altered), swelling in left armpit (peripheral swelling), sweating (hyperhidrosis), bad abdominal pain (abdominal pain), felt double over pain in stomach (abdominal pain upper), thirstiness (thirst), fatigue, headache and nausea.  The patient's medical history includes allergies. No concomitant medications were indicated.  On 13-Jan-2021, at 9:30 AM, this patient received the first planned doses of mRNA-1273 (Lot/Batch number: Not reported) intramuscularly to the right arm for prophylaxis of COVID-19 infection.   On 13-Jan-2021, later that afternoon after her vaccination, this patient felt fatigue, blurry vision, headache, thirstiness, moody, swelling in left armpit and nausea. On 14-Jan-2021, at 2:00 AM, the patient had bad abdominal pain, nausea, sweating, black out feeling and felt double over in pain in stomach. A couple of days later all symptoms went away, except for swelling in left armpit. Her HCP (Health Care Professional) said it's okay for her to get the second dose.   Action taken with mRNA-1273 in response to the events was not provided/unknown.  The outcome for the events, black out like feeling, blurry vision, moody, sweating, bad abdominal pain, felt double over pain in stomach, thirstiness, fatigue, headache and nausea, is recovered. The outcome for the event, swelling in left armpit (peripheral swelling), is not recovered.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Mood altered, Nausea, Peripheral swelling, Thirst
Clinical narrative: Black out like feeling; Sweating; Bad adnominal pain; Felt double over pain in stomach; Thirstiness; Fatigue; Headache; Nausea; Blurry Vision; Moody; Swelling in left armpit; This spontaneous report was received from a consumer concerning a female patient (age not provided) who experienced black out like feeling (feeling abnormal), blurry vision (vision blurred), moody (mood altered), swelling in left armpit (peripheral swelling), sweating (hyperhidrosis), bad abdominal pain (abdominal pain), felt double over pain in stomach (abdominal pain upper), thirstiness (thirst), fatigue, headache and nausea.  The patient's medical history includes allergies. No concomitant medications were indicated.  On 13-Jan-2021, at 9:30 AM, this patient received the first planned doses of mRNA-1273 (Lot/Batch number: Not reported) intramuscularly to the right arm for prophylaxis of COVID-19 infection.   On 13-Jan-2021, later that afternoon after her vaccination, this patient felt fatigue, blurry vision, headache, thirstiness, moody, swelling in left armpit and nausea. On 14-Jan-2021, at 2:00 AM, the patient had bad abdominal pain, nausea, sweating, black out feeling and felt double over in pain in stomach. A couple of days later all symptoms went away, except for swelling in left armpit. Her HCP (Health Care Professional) said it's okay for her to get the second dose.   Action taken with mRNA-1273 in response to the events was not provided/unknown.  The outcome for the events, black out like feeling, blurry vision, moody, sweating, bad abdominal pain, felt double over pain in stomach, thirstiness, fatigue, headache and nausea, is recovered. The outcome for the event, swelling in left armpit (peripheral swelling), is not recovered.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: Black out like feeling; Sweating; Bad adnominal pain; Felt double over pain in stomach; Thirstiness; Fatigue; Headache; Nausea; Blurry Vision; Moody; Swelling in left armpit; This spontaneous report was received from a consumer concerning a female patient (age not provided) who experienced black out like feeling (feeling abnormal), blurry vision (vision blurred), moody (mood altered), swelling in left armpit (peripheral swelling), sweating (hyperhidrosis), bad abdominal pain (abdominal pain), felt double over pain in stomach (abdominal pain upper), thirstiness (thirst), fatigue, headache and nausea.  The patient's medical history includes allergies. No concomitant medications were indicated.  On 13-Jan-2021, at 9:30 AM, this patient received the first planned doses of mRNA-1273 (Lot/Batch number: Not reported) intramuscularly to the right arm for prophylaxis of COVID-19 infection.   On 13-Jan-2021, later that afternoon after her vaccination, this patient felt fatigue, blurry vision, headache, thirstiness, moody, swelling in left armpit and nausea. On 14-Jan-2021, at 2:00 AM, the patient had bad abdominal pain, nausea, sweating, black out feeling and felt double over in pain in stomach. A couple of days later all symptoms went away, except for swelling in left armpit. Her HCP (Health Care Professional) said it's okay for her to get the second dose.   Action taken with mRNA-1273 in response to the events was not provided/unknown.  The outcome for the events, black out like feeling, blurry vision, moody, sweating, bad abdominal pain, felt double over pain in stomach, thirstiness, fatigue, headache and nausea, is recovered. The outcome for the event, swelling in left armpit (peripheral swelling), is not recovered.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pruritus, Skin swelling, Vaccination site erythema, Vaccination site reaction
Clinical narrative: 2.5 diameter circles below injection site; Hot to the touch; Puffy; Itchy; Swollen lymph node under arm; Redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (2.5 diameter circles below injection site), VACCINATION SITE WARMTH (Hot to the touch), SKIN SWELLING (Puffy), PRURITUS (Itchy) and LYMPHADENOPATHY (Swollen lymph node under arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Oill2OA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE REACTION (2.5 diameter circles below injection site), VACCINATION SITE WARMTH (Hot to the touch), SKIN SWELLING (Puffy), PRURITUS (Itchy), LYMPHADENOPATHY (Swollen lymph node under arm) and VACCINATION SITE ERYTHEMA (Redness). The patient was treated with SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM) at an unspecified dose and frequency. On 29-Jan-2021, VACCINATION SITE REACTION (2.5 diameter circles below injection site), VACCINATION SITE WARMTH (Hot to the touch), SKIN SWELLING (Puffy), PRURITUS (Itchy) and VACCINATION SITE ERYTHEMA (Redness) had resolved. At the time of the report, LYMPHADENOPATHY (Swollen lymph node under arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication list was not provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: 2.5 diameter circles below injection site; Hot to the touch; Puffy; Itchy; Swollen lymph node under arm; Redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (2.5 diameter circles below injection site), VACCINATION SITE WARMTH (Hot to the touch), SKIN SWELLING (Puffy), PRURITUS (Itchy) and LYMPHADENOPATHY (Swollen lymph node under arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Oill2OA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE REACTION (2.5 diameter circles below injection site), VACCINATION SITE WARMTH (Hot to the touch), SKIN SWELLING (Puffy), PRURITUS (Itchy), LYMPHADENOPATHY (Swollen lymph node under arm) and VACCINATION SITE ERYTHEMA (Redness). The patient was treated with SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM) at an unspecified dose and frequency. On 29-Jan-2021, VACCINATION SITE REACTION (2.5 diameter circles below injection site), VACCINATION SITE WARMTH (Hot to the touch), SKIN SWELLING (Puffy), PRURITUS (Itchy) and VACCINATION SITE ERYTHEMA (Redness) had resolved. At the time of the report, LYMPHADENOPATHY (Swollen lymph node under arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication list was not provided.